As weight loss injectables become more widely available, many people wonder whether metformin is now outdated or whether ...

Diabetic retinopathy, caused by high blood sugar, is a leading cause of vision loss globally, affecting millions including 65 million in India.

A review highlights hearing loss as a hidden complication of type 2 diabetes. It notes that roughly 1 in 4 experience hearing impairment, and those with diabetes are more than twice as likely to have ...

To deal with a leaky gut, your body shunts sugar to your immune system, causing insulin resistance, metabolic syndrome, and ...

India has launched Awiqli, the world's first once-weekly insulin, offering fewer injections and potentially improving ...

Eli Lilly Canada announced today that Mounjaro® (tirzepatide), the first and only Health Canada-authorized once-weekly glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 ...

A new study suggests GLP-1 medications, such as semaglutide, were associated with better overall outcomes in people with type ...

Type 2 diabetes remission is possible with early intervention, significant weight loss and evidence-based care, but it's not ...

A new study by University of Manchester researchers has linked a digital platform helping people manage type 2 diabetes to better blood sugar control, improved health and potential long-term NHS cost ...

Ambitious studies have been examining the protective effects of diet, exercise and socializing — with surprising results.

When you're trying to control your blood sugar, you may think sweets are off the table. Yet, the messages can get confusing. Dark chocolate is also praised as healthy—or at least a healthier ...

Novo Nordisk says Awiqli can cut basal insulin shots from 365 to 52 a year, targeting delayed insulin use in India’s vast diabetes market.